Related Experiment Videos
TRH-induced antinociception: interaction with the opioid systems?
General Pharmacology
|January 1, 1987
Summary
Thyrotropin-releasing hormone (TRH) reduced pain responses in non-tolerant mice but not in those with opioid tolerance. TRH did not affect opioid receptor binding, suggesting it does not interact with these receptors.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Opioid tolerance is a significant challenge in pain management.
- Thyrotropin-releasing hormone (TRH) has shown potential analgesic properties.
Purpose of the Study:
- To investigate the effect of TRH on antinociception in opioid-tolerant mice.
- To determine if TRH interacts with opioid receptors.
Main Methods:
- Induction of tolerance to morphine and ethylketocyclazocine in mice.
- Assessment of TRH's antinociceptive effect using the phenyl-p-benzoquinone writhing test.
- Evaluation of TRH's effect on [3H]naloxone and [3H]lofentanil binding in mouse brain tissue.
Main Results:
- TRH significantly reduced writhes in non-tolerant mice but not in morphine- or ethylketocyclazocine-tolerant mice.
- TRH did not alter the in vitro or ex vivo binding of [3H]naloxone.
- No dose-dependent modification of in vivo [3H]lofentanil binding was observed after TRH administration.
Conclusions:
- TRH's antinociceptive effect is diminished in the presence of opioid tolerance.
- TRH does not appear to interact directly with opioid receptors (naloxone or lofentanil binding sites).
- These findings suggest TRH-mediated analgesia may involve non-opioid pathways or is modulated by opioid tolerance mechanisms.